%0 Journal Article
%A 
%T Clinicopathological Characteristics of Patients with HR-Positive/HER2-Negative Metastatic Breast Cancer Experiencing Early Progression Within 6 Months of CDK4/6 Inhibitor Therapy
%D 2026
%F 
%P 433-440
%V 10
%N 3
%R doi:10.14744/ejmi.269433
%U https://dx.doi.org/10.14744/ejmi.269433